First patient dosed in phase II Telix Starburst trial

The first patient has been dosed in Telix Pharmaceuticals' carbonic anhydrase-targetin...Read more on AuntMinnie.comRelated Reading: Telix acquires Dedicaid for $1.2M Telix gets FDA nod for gallium injection prep kit Telix makes two new executive appointments Telix highlights kidney cancer imaging study results Telix relocates U.S. headquarters
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news